Navigation Links
Pharmion to Present Clinical Data on Commercial and Pipeline,Products at 2007 American Society of Clinical Oncology (ASCO),Meeting

on Cancer Center; Abstract #3547; June 2, 2007; 2:00-6:00pm; McCormick Place Convention Center, S102a

MGCD0103

Oral Presentation: A Phase II Study of a Novel Oral Isotype-Selective Histone Deacetylase (HDAC) Inhibitor in Patients With Relapsed or Refractory Hodgkin's lymphoma -- A. Younes, MD, MD Anderson Cancer Center; Abstract #8000; June 2, 2007; 3:00-3:15pm; McCormick Convention Center, E450b

Phase I/II study of a novel oral isotype-selective histone deacetylase (HDAC) inhibitor MGCD0103 in combination with azacitidine in patients (pts) with high-risk Myelodysplastic Syndrome (MDS) or Acute Myelogenous Leukemia (AML) -- G. Garcia-Manero, MD, MD Anderson Cancer Center; Abstract #7062; June 2, 2007; 8:00am-12:00pm; McCormick Convention Center, S Hall A2

A Phase I study of MGCD0103 given as a twice weekly oral dose in patients with advanced leukemias or myelodysplastic syndromes (MDS) -- J. Lancet, MD, H. Lee Moffitt Cancer Center; Abstract #2516; June 4, 2007; 2:00-6:00pm; McCormick Convention Center, S102a

Thalidomide

Oral Presentation: Melphalan-Prednisone-Thalidomide (MP-T) is also superior to Melphalan-Prednisone (MP) in patients 75 years of age or older with untreated multiple myeloma (MM). Preliminary results of the randomized, double-blind, placebo-controlled IFM 01-01 trial -- C. Hulin, IFM, France; Abstract #8001; June 4, 2007; 7:30-7:45am; McCormick Place Convention Center, E Arie Crown Theater

Oral Presentation: Long-term responses to thalidomide and rituximab in Waldenstrom's macroglobulinemia -- J. Soumera; Abstract #8017; June 3, 2007; 1:00-1:15pm; McCormick Place Convention Center, E354b

Oral Presentation: Impact of prior thalidomide (T) therapy on the efficacy of pegylated liposomal doxorubicin (PLD) and bortezomib (B) in relapsed/refractory multiple myeloma (RRMM) -- P. Sonneveld; Abstract #8023; June 3, 2007; 3:00-3:15pm; McCormick Place Convention Center, E354b

An analysis of erythro
'"/>




Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Pharmions Amrubicin Shows Encouraging Results Compared to Standard of Care in Second Line Treatment of Small Cell Lung Cancer
2. The Past, Present and Future of HLA Typing
3. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
4. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
5. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
6. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
7. Generex Biotechnology to Make Presentations At 46th Annual Meeting of the European Society of Pediatric Endocrinology
8. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
9. ViaCell to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
10. Accelrys to Present to Investors at C.E. Unterberg Emerging Growth Opportunities Conference
11. Metabasis to Present at C.E. Unterberg, Towbin Emerging Growth Conference and Attend Pacific Growth Equities Conference

Post Your Comments:
(Date:11/6/2009)...FirstCall/ -- Keryx Biopharmaceuticals, Inc. (Nasd..., November 10, 2009 at 8:30 a.m. EST to discuss th...s outlook for the remainder of 2009. Ron Bentsur,... the call. Keryx will announce its financial resu...d prior to the call. ,, In order to participate...
(Date:11/6/2009)...irstCall/ -- Caraco Pharmaceutical Laboratories, L...ethamine ophthalmic solution, 0.5% following a fin...on (FDA) for Sun Pharma,s Abbreviated New Drug App... solution on the first day following patent expira...y equivalent to Acular® Ophthalmic Solution, ...
(Date:11/5/2009)...5 Transcept Pharmaceutic...ical company focused on the development and commer...mportant therapeutic needs in the field of neurosc...teleconference with management to discuss third qu... 12, 2009, at 5:00 p.m. Eastern Standard Time. Fi...
Breaking Medicine Technology:Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Third Quarter 2009 Financial Results on Tuesday, November 10, 2009 at 8:30 a.m. EST 2Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Acular(R) Opthalmic Solution 2Transcept Pharmaceuticals to Report Third Quarter 2009 Results and Host Conference Call on November 12 2The Vision Revolution 3A Eyes are the source of human superpowers 8866 1The Vision Revolution 3A Eyes are the source of human superpowers 8866 2GlaxoSmithKline 13th Annual IMPACT Awards Seek Nonprofits Providing Access to Healthcare 49110 1GlaxoSmithKline 13th Annual IMPACT Awards Seek Nonprofits Providing Access to Healthcare 49110 2Doctor Diabetic Supply Inc Acquires Diabetes Source Rx 49107 1Doctor Diabetic Supply Inc Acquires Diabetes Source Rx 49107 2
...Aug. 26 Omeros Corporation today announced the,pu...ial investigating,OMS103HP in arthroscopic anterio...OMS103HP is an investigational drug product that i... designed to improve postoperative,knee function a...ients an,earlier return to work. The article title...
...alls it a ,miracle, LATHAM, N.Y., Aug. 25 Clinic...am at Community Care Physicians in,Latham have com...,radiotherapy technology from Varian Medical Syste...ighly-precise image-guided,intensity-modulated rad..., RapidArc treatments spare healthy tissue and ot...
Other Medicine Technology:Omeros Announces Publication of Clinical Results for OMS103HP in Arthroscopy: The Journal of Arthroscopic and Related Surgery 2Image Guided Radiation Therapy in Latham, NY. Now Fighting Cancer Using Fast and Precise RapidArc(TM) Radiotherapy Technology 2Image Guided Radiation Therapy in Latham, NY. Now Fighting Cancer Using Fast and Precise RapidArc(TM) Radiotherapy Technology 3
(Date:11/8/2009)...7 Today, the House of R...ahlkemper, Smith, Ellsworth and Lipinski amendment...H.R. 3962). The amendment maintains the current po...d for benefits packages that include abortion. It ... affordability credits and those who do not, can w...
(Date:11/8/2009)...Passage of H.R. 3961 to Secure the Stability of Me...re/ -- Statement Attributable to: J. James Rohack,..., (Logo: http://www.newscom.com/cgi-bin/prnh/2...ge of the House health reform bill, which will hel...cians and calls for swift passage of H.R. 3961 to ...
(Date:11/8/2009)..., Nov. 8 March of Dimes...ncheon to recognize prominent individuals who are ...e role models for March of Dimes commitment to imp...f Dimes November Prematurity Awareness Month campa...join the fight for preemies! ,, (Photo: http:...
(Date:11/7/2009)...eman (CT), David A. Cook (GA), Louis J. Goodman (T...ored ,, CHICAGO, Nov. 7 /PRNewswire-USNewswire...presented five medical society executive leaders w...s to the goals and ideals of the medical professio...ual policy making meeting in Houston. ,, (Logo...
(Date:11/7/2009)...7 The U.S. bishops Nove...es to vote for the Stupak-Ellsworth Amendment to t...-Pitts-Kaptur-Dahlkemper-Lipinski-Smith Amendment ... funding and conscience protections in the Afforda... said. ,, The letter was signed by Cardinal Jus...
Breaking Medicine News(10 mins):Health News:Family Research Council Praises Passage of Pro-life Amendment to Health Care Bill 2Health News:AMA Hails House Passage of Health Reform Bill (H.R. 3962) 2Health News:Hollywood Stars Joined in a Celebration of Babies 2Health News:Hollywood Stars Joined in a Celebration of Babies 3Health News:AMA Honors Medical Society Executives 2Health News:Bishops Urge Passage of Stupak-Ellsworth Anti-Abortion Amendment for Health Reform Bill 2
...moving thousands of jars of pasta sauces because t...gasoline and shoe polish.// Sky News said con...ds, including Bertolli, as well as private-label s... the sauces. The dye -- classified as a carcinogen...
...es among adolescents has alarmed researchers who s... Researchers at the Mayo Clinic in Rochester, M...ared it with information recorded between 1999 and...ep Khosla, an endocrinologist at the clinic and th...
... occur during adolescence may mean teenagers smoke... those who take up the habit as adults, suggests a...sted that the earlier someone starts smoking, the ...ke University Medical Center in Durham, North Caro...
...nking tea may be more than skin-deep. Researchers ...veloped a new cream, made of tea, they say could f... which researchers say appear to block skin tumors...crease levels of the enzyme JNK-2, which naturally...
...ress Syndrome is a severe injury to most or all of...ess of breath and often are on life support. //A n...ance of developing ARDS after a trauma. ARDS ...a. Researchers from the University of Washington S...
...paghetti? A greenish banana faster than a freckled...experts.They are convinced that carbohydrates shou.../ The debate involves an idea called the glycem...a blast of sugar makes insulin levels go up, and t...
Other Medicine News:Health News:Teens break bones 'due to lack of milk' 2Health News:Good carb, bad carb? Experts debate. 2Health News:Good carb, bad carb? Experts debate. 3
...he widest offering of single-use instruments on th...long 43cm lengths for Bariatric Surgery. , Dual a...sulation covers the pivot points to reduce the cha...cord, which eliminates gapping at connection and t...
MultAcoice™™ Rongeur Handle With Ratchet and Monopolar Cautery
MultAcoice™ 5 mm Insulated Outer Shaft
...order products are offered as 1-piece or modular, ...ruments may be customized with handles of choice a...flush ports. Many standard patterns are available ...ffect delivery times. , Please Note: Individual ...
Medicine Products: